AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteBetamethasone valerate is a potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
More Information Supplier PageBetamethasone valerate is a potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
More Information Supplier PageBetamethasone valerate is a potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
More Information Supplier PageBetamethasone valerate is a potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
More Information Supplier PageBetaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol.
More Information Supplier PageBetaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol.
More Information Supplier PageBetaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol.
More Information Supplier PageBetaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol.
More Information Supplier PageBethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors.
More Information Supplier PageBethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors.
More Information Supplier PageBethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors.
More Information Supplier PageBETP is a selective positive allosteric modulator and partial agonist of the glucagon-like peptide 1 (GLP-1) receptor.
More Information Supplier PageBETP is a selective positive allosteric modulator and partial agonist of the glucagon-like peptide 1 (GLP-1) receptor.
More Information Supplier PageBETP is a selective positive allosteric modulator and partial agonist of the glucagon-like peptide 1 (GLP-1) receptor.
More Information Supplier PageBetrixaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is potent, orally active and highly selective for factor Xa, being selected from a group of similar compounds for its low hERG affinity.
More Information Supplier PageBetrixaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is potent, orally active and highly selective for factor Xa, being selected from a group of similar compounds for its low hERG affinity.
More Information Supplier PageBetrixaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is potent, orally active and highly selective for factor Xa, being selected from a group of similar compounds for its low hERG affinity.
More Information Supplier PageBetrixaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is potent, orally active and highly selective for factor Xa, being selected from a group of similar compounds for its low hERG affinity.
More Information Supplier PageBetulin is a triterpene with a pentacyclic ring structure and hydroxyl groups in positions C3 and C28. Betulin has protective effects against cadmium induced apoptosis in human hepatoma cell lines.
More Information Supplier PageBetulin is a triterpene with a pentacyclic ring structure and hydroxyl groups in positions C3 and C28. Betulin has protective effects against cadmium induced apoptosis in human hepatoma cell lines.
More Information Supplier PageBetulinaldehyde is a potential antitubercular molecule isolated from plant Ziziphus cambodiana.
More Information Supplier PageBetulinaldehyde is a potential antitubercular molecule isolated from plant Ziziphus cambodiana.
More Information Supplier PageBetulinaldehyde is a potential antitubercular molecule isolated from plant Ziziphus cambodiana.
More Information Supplier PageBetulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties.
More Information Supplier PageBetulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties.
More Information Supplier PageBetulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties.
More Information Supplier PageBetulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties.
More Information Supplier PageBetulinic acid is a naturally occurring pentacyclic triterpenoid which has antiretroviral, antimalarial, and anti-inflammatory properties.
More Information Supplier PageBEZ235 (NVP-BEZ235) inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.
More Information Supplier PageBEZ235 (NVP-BEZ235) inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.
More Information Supplier PageBEZ235 (NVP-BEZ235) inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.
More Information Supplier PageBEZ235 (NVP-BEZ235) inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.
More Information Supplier Page
